Featured episode
Cultivating resilience: Building a better supply chain with McKesson’s Ammie McAsey
Learn how Ammie McAsey is working to connect the healthcare supply chain across the ecosystem to bring additional access and benefits to patients and where she sees the most potential for innovation.
FEATURED EPISODE
‘We can’t do it alone’: UCB’s Colin Lake on partnerships, patients and rare diseases
Colin Lake, VP and head of digital care transformation, neurology and rare disease at UCB, is passionate about helping patients with rare diseases. Learn about UCB’s digital strategy to address key pain points for patients.
FEATURED EPISODE
‘The hinge moment’: Envisioning transformation with Amgen’s Alex Koehler
How should pharma companies respond to the current “hinge moment” where new technologies are enabling breakthroughs in drug discovery, manufacturing and customer engagement? Guest Alex Koehler of Amgen believes it’s time to be bold and move faster.
Featured episode
‘We’re all tech leaders now’: A conversation with Salesforce’s Kyrsten Musich
The opportunities to reshape customer engagement have never been greater for pharma, but what role does the customer relationship management (CRM) system play? Kyrsten Musich, vice president of healthcare and life sciences at Salesforce, shares why pharma leaders need to be directly involved in shaping the vision and strategy for CRM to drive true competitive advantage.
Featured episode
How CRM can help pharma break barriers and transform customer engagement
Drive behavior-changing personalized customer engagement at scale by addressing customer barriers with a powerful customer relationship management system. ZS experts talk with Maria Whitman about how companies can get started.
FEATURED EPISODE
Expanding access to cell and gene therapies with McKesson’s Joe DePinto
Joe DePinto, McKesson’s head of cell and gene advanced therapies, is passionate about helping patients get access to these groundbreaking therapeutic interventions. Maria Whitman gets Joe’s perspective on the current state of cell and gene therapy.
- A
- B
- C
- D
- E
- F
Miniseries
- Future of Commercial Model
- Future of Health
- Precision Medicine
Pharma's commercial model of tomorrow starts today
Building connections to reimagine healthcare
How biopharma can mobilize to design, develop and deliver precision medicine
About the Host
Maria Whitman is ZS’s managing partner, global commercialization strategy and solutions. A longtime leader in life sciences, she is dedicated to advancing health. She advises on strategy for top pharmaceutical and biotech companies to drive performance and engagement in the ecosystem to improve patient outcomes.